Renal denervation for hypertension management in the UK: a Delphi expert consensus

Peter Alexander John Haworth, Clare Bent, Neil Chapman, Rasha Kadem Al-Lamee, Indranil Dasgupta, Terry McCormack, Kazem Rahimi · 2026

Read Renal denervation for hypertension management in the UK: a Delphi expert consensus by Peter Alexander John Haworth, Clare Bent, Neil Chapman, Rasha Kadem Al-Lamee, Indranil Dasgupta, Terry McCormack, Kazem Rahimi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13479678.txt.

Description

BackgroundRenal denervation (RDN) has emerged as a guideline-recommended therapeutic option in hypertension management with several high-quality, randomised, placebo-controlled trials demonstrating efficacy and safety. However, the lack of expert consensus on patient selection for RDN in the UK has led to debate regarding its use.

Catalog record

CREATORPeter Alexander John Haworth, Clare Bent, Neil Chapman, Rasha Kadem Al-Lamee, Indranil Dasgupta, Terry McCormack, Kazem Rahimi
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE37 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13479678

Browse the full library · About the Tower of Babel